Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Bisphosphonates have been used extensively in the treatment and the prevention of skeletal
complications associated with bone metastases in patients with breast cancer and prostate
cancer.
The purpose of this study is to assess the effect of zoledronic acid patients with prostate
cancer or breast cancer and bone metastasis.